Our findings indicate a temperate CD4+ T-cell response in the peripheral blood of old melanoma patients, whereas CD4+ T cells of young melanoma patients showed prominent signs of activation, proliferation, and differentiation. This evidence concerns the gene CD4 and melanoma.